Evaluation of PD-L1-stained tumor cells via the 22C3 and SP-142 antibodies in cohort of patients treated on KEYNOTE-001 Meeting Abstract


Authors: Lisberg, A.; Hu-Lieskovan, S.; Grogan, T.; Carroll, J.; Shintaku, P.; Han, M.; Slamon, D.; Dubinett, S.; Goldman, J.; Elashoff, D.; Hellmann, M.; Ribas, A.; Garon, E.
Abstract Title: Evaluation of PD-L1-stained tumor cells via the 22C3 and SP-142 antibodies in cohort of patients treated on KEYNOTE-001
Meeting Title: IASLC 19th World Conference on Lung Cancer
Keywords: pd-l1; pembrolizumab; keynote-001
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 10 Suppl.
Meeting Dates: 2018 Sep 23-26
Meeting Location: Toronto, Canada
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-10-01
Start Page: S761
Language: English
ACCESSION: WOS:000454014502452
DOI: 10.1016/j.jtho.2018.08.1302
PROVIDER: wos
Notes: Meeting Abstract: P2.09-05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann